Heartflow (NASDAQ:HTFL) CFO Sells 668 Shares of Stock

Key Points

• Heartflow CFO Vikram Verghese sold 668 shares at an average price of $50.01, generating $33,406.68. The transaction was conducted under a pre-arranged Rule 10b5-1 plan, and he retained 179,528 shares.
• Heartflow reported strong quarterly momentum, with revenue rising 47.7% year over year to $64.08 million and a loss of $0.07 per share, better than the $0.22-per-share consensus estimate.
• HTFL traded at $48.33 after falling $1.21, while analysts maintained a broadly favorable outlook with a consensus “Moderate Buy” rating and an average price target of $44.88.

Heartflow, Inc. (NASDAQ:HTFL - Get Free Report) CFO Vikram Verghese sold 668 shares of the stock in a transaction on Tuesday, September 15th. The stock was sold at an average price of $50.01, for a total transaction of $33,406.68. Following the sale, the chief financial officer directly owned 179,528 shares in the company, valued at $8,978,195.28. This trade represents a 0.37% decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Vikram Verghese also recently made the following trade(s):

• On Monday, September 14th, Vikram Verghese sold 4,593 shares of Heartflow stock. The stock was sold at an average price of $50.24, for a total transaction of $230,752.32.
• On Friday, September 11th, Vikram Verghese sold 29,714 shares of Heartflow stock. The shares were sold at an average price of $50.06, for a total value of $1,487,482.84.
• On Tuesday, September 8th, Vikram Verghese sold 6,640 shares of Heartflow stock. The stock was sold at an average price of $50.03, for a total value of $332,199.20.
• On Thursday, September 3rd, Vikram Verghese sold 27,540 shares of Heartflow stock. The stock was sold at an average price of $49.69, for a total value of $1,368,462.60.
• On Wednesday, September 2nd, Vikram Verghese sold 5,876 shares of Heartflow stock. The stock was sold at an average price of $50.60, for a total transaction of $297,325.60.

Heartflow Price Performance

HTFL stock traded down $1.21 during trading on Tuesday, reaching $48.33. 2,031,448 shares of the stock traded hands, compared to its average volume of 1,972,264. Heartflow, Inc. has a 52-week low of $20.13 and a 52-week high of $51.78. The business's 50 day moving average price is $36.39 and its 200-day moving average price is $31.21. The firm has a market capitalization of $4.20 billion and a PE ratio of -26.41.

Heartflow (NASDAQ:HTFL - Get Free Report) last announced its quarterly earnings data on Thursday, August 13th. The company reported ($0.07) earnings per share (EPS) for the quarter, topping the consensus estimate of ($0.22) by $0.15. Heartflow had a negative return on equity of 23.52% and a negative net margin of 55.82%.The firm had revenue of $64.08 million for the quarter. The business's revenue was up 47.7% compared to the same quarter last year. On average, equities research analysts predict that Heartflow, Inc. will post -0.75 earnings per share for the current year.

Heartflow News Summary

Here are the key news stories impacting Heartflow this week:

• Positive Sentiment: Heartflow’s latest quarterly results showed strong operating momentum: revenue rose 47.7% year over year to $64.08 million, while its $0.07-per-share loss was narrower than analysts expected. Heartflow stock and earnings information
• Positive Sentiment: Several institutions recently initiated or increased positions, including Squarepoint Ops, which lifted its stake by 72%, providing a potential source of buying support.
• Positive Sentiment: Analyst sentiment remains broadly favorable, with a consensus “Moderate Buy” rating. UBS set a $55 price target, above the recent trading range, while other firms maintained Buy or Overweight ratings.
• Neutral Sentiment: The CFO’s sales were disclosed as part of a planned trading program, reducing the likelihood that the transactions represent a new negative view of Heartflow’s business. After selling 35,?—actually 35,? shares across September 11–15, CFO Vikram Verghese still owned roughly 179,528 shares.
• Negative Sentiment: CFO Vikram Verghese sold a combined 34,975 shares for approximately $1.75 million at prices near $50 per share, reducing his direct ownership by roughly 16.7% over the reported transactions. CFO SEC filing
• Negative Sentiment: CEO John Farquhar also sold 38,900 shares for approximately $1.82 million on September 10–11 and has reported multiple sales since June. The repeated selling by senior executives, particularly after the stock approached its 52-week high, is likely contributing to short-term pressure. HeartFlow CEO share sale

Analyst Upgrades and Downgrades

HTFL has been the subject of a number of research analyst reports. Stifel Nicolaus boosted their target price on Heartflow from $40.00 to $45.00 and gave the company a "buy" rating in a research note on Friday, August 14th. Piper Sandler reaffirmed an "overweight" rating and set a $45.00 target price (up from $38.00) on shares of Heartflow in a research note on Friday, August 14th. Wells Fargo & Company boosted their price target on shares of Heartflow from $37.00 to $39.00 and gave the company an "overweight" rating in a research note on Friday, August 14th. Robert W. Baird set a $45.00 price target on shares of Heartflow in a research report on Friday, August 14th. Finally, JPMorgan Chase & Co. boosted their price target on shares of Heartflow from $35.00 to $45.00 and gave the company an "overweight" rating in a research report on Friday, August 14th. One analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, two have assigned a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Heartflow has a consensus rating of "Moderate Buy" and an average target price of $44.88.

Institutional Inflows and Outflows

Hedge funds have recently added to or reduced their stakes in the business. XXEC Inc. purchased a new stake in Heartflow in the 2nd quarter worth approximately $2,524,764,000. BlackRock Inc. purchased a new stake in shares of Heartflow in the 2nd quarter valued at $152,502,000. Bamco Inc. NY acquired a new position in shares of Heartflow in the second quarter worth $94,625,000. Jupiter Topco LLC purchased a new stake in Heartflow during the 2nd quarter worth about $70,983,000. Finally, Janus Henderson Group PLC increased its stake in Heartflow by 152.0% in the first quarter. Janus Henderson Group PLC now owns 2,180,976 shares of the company's stock valued at $53,063,000 after purchasing an additional 1,315,416 shares during the period.

About Heartflow

Heartflow, Inc is a medical technology company that develops artificial intelligence and imaging solutions for the diagnosis and management of coronary artery disease. Its platform analyzes data from coronary computed tomography angiography (CCTA) scans to create personalized, three-dimensional models of a patient's coronary arteries.

The company's primary offering, Heartflow Analysis, is designed to provide noninvasive estimates of fractional flow reserve derived from computed tomography (FFR^CT).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.